Purchase Order 36C26222P0093
- Not listed
- This contract was awarded by the Department of Veterans Affairs Veterans Health Administration to Ameripath Inc., a subsidiary of Quest Diagnostics, to provide urgent anatomical pathology laboratory services and dermatopathology for the Southern Arizona VA Healthcare System. The one-year, firm fixed price delivery order, valued at $444,582.21, was awarded on October 1, 2017 and runs through September 30, 2018. The contract does not have a set-aside designation. Ameripath, through its Dermpath...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a $231,778.16 firm fixed-price purchase order to Ameripath Inc., Dermpath Diagnostics Division, on May 1, 2024, for dermatopathology testing services supporting the Southern Arizona Veterans Affairs Healthcare System in Tucson, Arizona. The contract, which extends through April 30, 2026, addresses the VA's need for urgent anatomic pathology laboratory services, including dermatopathology consultation on...
- The Department of Veterans Affairs, Veterans Integrated Service Network 22 (VISN 22), awarded a definitive firm fixed-price contract to Ameripath Inc., Dermpath Diagnostics Division (a subsidiary of Quest Diagnostics Incorporated) on December 1, 2023, for reference laboratory testing services. The contract ceiling value is $218,192.87 with an ultimate completion date of November 30, 2028. This procurement, which utilized full and open competition with no set-aside designation, addresses the...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 22 (VISN 22) to Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated. The contract, valued at $30,566.49, is for specialized anatomic pathology laboratory services to support the Southern Arizona Veterans Affairs Healthcare System (SAVAHCS) in Phoenix, Arizona. Ameripath Inc. will provide a range of diagnostic testing services, including dermatopathology, renal...
- This federal contract award is for the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 22 to obtain urgent anatomical pathology laboratory services and dermatopathology for the Southern Arizona VA Health Care System (SAVAHCS). The prime contractor is Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated, which specializes in advanced anatomic pathology testing. This is a delivery order with a firm fixed price contract type, valued at $80,000.00, and has an...
- This is a $101,612.61 firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Ameripath Inc. Dermpath Diagnostics Division, a subsidiary of Quest Diagnostics Incorporated. The contract is for reference laboratory testing services, including processing and analyzing patient specimens, providing consultations on prepared pathology slides, and offering dermatopathology services to support the Southern Arizona Veterans Affairs Healthcare System (SAVAHCS) in Tucson,...
- This federal contract award is for anatomic pathology testing services provided by Ameripath Inc. Dermpath Diagnostics, a subsidiary of Quest Diagnostics Incorporated. The contract is a Blanket Purchase Agreement (BPA) call with the Department of Veterans Affairs' Veterans Integrated Service Network (VISN) 19, with a ceiling value of $23,969.57 and an ultimate completion date of September 29, 2026. The contract is for firm-fixed-price services and does not have a set-aside designation. Ameripath...
- Ameripath Inc., a subsidiary of Quest Diagnostics Incorporated, received a $76,151.52 firm fixed-price BPA call award from the Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) for anatomic pathology testing services. The contract award, issued on September 30, 2024, with an ultimate completion date of September 29, 2025, was made without a set-aside designation, indicating full and open competition. The services will be performed in Oklahoma City, Oklahoma, and...
- This is a $12,854.93 fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs to Quest Diagnostics Incorporated, a provider of diagnostic information services, for surgical pathology consults and specialized testing services. The contract was awarded on October 1, 2020 and has an ultimate completion date of September 30, 2024. It was not set aside for any specific type of small business. The contract originated from a...
- This is a Firm Fixed Price Delivery Order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Quest Diagnostics Incorporated, a for-profit provider of diagnostic information services, to perform reference lab testing. The contract has a potential value of $397,050.82 and a completion date of September 30, 2023. The contract is not set aside for any specific business category. This award is part of the VA VHA's efforts to supplement in-house clinical testing...
Ameripath Inc.'s Dermpath Diagnostics division has been awarded a $99,659.48 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to provide reference laboratory testing services. The contract has no set-aside designation and calls for Ameripath to process and transport time-sensitive patient specimens, ensure integrity of prepared specimen slides, and provide specialized testing not available within VA medical centers in Tucson, Arizona. Services will be completed by November 2, 2022 to support the Southern Arizona VA Healthcare System. Ameripath is a subsidiary of Quest Diagnostics Incorporated, a leading provider of diagnostic information services to federal agencies through indefinite delivery contracts and task orders for clinical laboratory testing and analysis services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($8k) | 2/6/24 | |
| P00001 | Funding Only Action | $72.0k | 6/9/22 | |
| Not listed | Not listed | $36.0k | 11/1/21 |